FDA Homepage
Advancing toward the goal of global approval for generic drugs
- FDA proposes critical first steps to harmonize global standards for generic drugs
- Advancing toward the goal of global approval for generic drugs
FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarettes
- Targets nearly 10.7 million at-risk youth amid evidence of sharply rising use
- FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarettes
News & Events
- November 20, 2018 - FDA approves first treatment specifically for patients with rare and life-threatening type of immune disease
- November 19, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim for consuming oils with high levels of oleic acid to reduce coronary heart disease risk
- November 16, 2018 - FDA approves new drug to treat travelers’ diarrhea
Newsroom
Recent Consumer Updates
Browse by Audience
-
For Consumers
Updates and information for staying safe and healthy -
For Patients
Learn about other treatments, drug/device approvals, public meetings and more -
For Health Professionals
Medical product safety information, adverse event/problem reporting and more -
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more -
For Industry
Guidance, registration and listing, pay user fees, import programs and more
FDA Voices:
Perspectives from FDA Experts
Page Last Updated: 11/20/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English